Anna Salim

Anna Salim, CFA, is a seasoned VC Investment Portfolio Manager at Canaccord Genuity Asset Management, specializing in technology-led early-stage and growth investments across various sectors, including enterprise software, healthcare, biotech, and industrial tech since April 2018. Notable investments include Gousto, Zappar, and Maxcyte, among others. In addition to primary responsibilities, Anna serves as an Investor and Board Observer at Qureight and holds investment roles in several companies, including Arecor Therapeutics plc and Eagle Eye. Anna is a member of Angel Academe, promoting female investment. An academic background includes a Postgraduate Degree in Artificial Intelligence for Business from Saïd Business School, University of Oxford, and degrees in Economics and MBA from prestigious institutions.